Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk NVO revealed 11 unusual trades.
Delving into the details, we found 72% of traders were bullish, while 18% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $712,181, and 5 were calls, valued at $327,380.
Projected Price Targets
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $70.0 and $100.0 for Novo Nordisk, spanning the last three months.
Volume & Open Interest Development
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Novo Nordisk's significant trades, within a strike price range of $70.0 to $100.0, over the past month.
Novo Nordisk Option Activity Analysis: Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | PUT | TRADE | BULLISH | 06/20/25 | $3.4 | $3.2 | $3.2 | $70.00 | $250.5K | 631 | 1.8K |
| NVO | PUT | SWEEP | BULLISH | 06/20/25 | $3.3 | $3.2 | $3.2 | $70.00 | $209.3K | 631 | 907 |
| NVO | PUT | SWEEP | BEARISH | 06/20/25 | $3.3 | $3.25 | $3.3 | $70.00 | $137.6K | 631 | 449 |
| NVO | CALL | TRADE | BULLISH | 09/19/25 | $10.1 | $9.7 | $10.1 | $80.00 | $101.0K | 282 | 100 |
| NVO | CALL | TRADE | BULLISH | 01/24/25 | $3.0 | $2.86 | $3.0 | $77.00 | $96.3K | 26 | 0 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
After a thorough review of the options trading surrounding Novo Nordisk, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Where Is Novo Nordisk Standing Right Now?
- Currently trading with a volume of 353,083, the NVO's price is up by 1.36%, now at $79.76.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 15 days.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novo Nordisk options trades with real-time alerts from Benzinga Pro.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
